nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—lung cancer	0.477	1	CbGaD
Letrozole—CYP19A1—Paclitaxel—lung cancer	0.0941	0.357	CbGbCtD
Letrozole—CYP3A4—Topotecan—lung cancer	0.0241	0.0913	CbGbCtD
Letrozole—CYP3A4—Gefitinib—lung cancer	0.022	0.0835	CbGbCtD
Letrozole—CYP3A4—Teniposide—lung cancer	0.0214	0.081	CbGbCtD
Letrozole—CYP3A4—Vinorelbine—lung cancer	0.017	0.0644	CbGbCtD
Letrozole—CYP3A4—Crizotinib—lung cancer	0.0135	0.0512	CbGbCtD
Letrozole—CYP3A4—Erlotinib—lung cancer	0.013	0.0494	CbGbCtD
Letrozole—CYP3A4—Paclitaxel—lung cancer	0.0119	0.0452	CbGbCtD
Letrozole—CYP3A4—Irinotecan—lung cancer	0.0118	0.0446	CbGbCtD
Letrozole—CYP3A4—Vinblastine—lung cancer	0.0105	0.0397	CbGbCtD
Letrozole—CYP3A4—Etoposide—lung cancer	0.00942	0.0357	CbGbCtD
Letrozole—CYP3A4—Docetaxel—lung cancer	0.00862	0.0327	CbGbCtD
Letrozole—CYP3A4—Doxorubicin—lung cancer	0.00643	0.0244	CbGbCtD
Letrozole—Bifonazole—CYP2E1—lung cancer	0.000524	1	CrCbGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000106	0.00173	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TP53—lung cancer	0.000102	0.00167	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTM1—lung cancer	0.000102	0.00167	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTP1—lung cancer	0.0001	0.00165	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—GSTM1—lung cancer	0.0001	0.00164	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP1A1—lung cancer	9.64e-05	0.00158	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—lung cancer	9.59e-05	0.00157	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP1A1—lung cancer	9.51e-05	0.00156	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTM1—lung cancer	9.23e-05	0.00151	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	9.09e-05	0.00149	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CAT—lung cancer	9.02e-05	0.00148	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	8.97e-05	0.00147	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GSTP1—lung cancer	8.81e-05	0.00144	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTM2—lung cancer	8.77e-05	0.00144	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CNDP2—lung cancer	8.77e-05	0.00144	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	8.67e-05	0.00142	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	8.65e-05	0.00142	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—COL4A3BP—lung cancer	8.48e-05	0.00139	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AZIN2—lung cancer	8.48e-05	0.00139	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GSTM1—lung cancer	8.09e-05	0.00133	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	8.08e-05	0.00132	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP2A7—lung cancer	7.93e-05	0.0013	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	7.91e-05	0.0013	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—lung cancer	7.88e-05	0.00129	CbGpPWpGaD
Letrozole—Influenza—Doxorubicin—lung cancer	7.86e-05	0.000398	CcSEcCtD
Letrozole—Leukopenia—Docetaxel—lung cancer	7.86e-05	0.000398	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	7.82e-05	0.00128	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—lung cancer	7.8e-05	0.00128	CbGpPWpGaD
Letrozole—Sweating—Methotrexate—lung cancer	7.76e-05	0.000393	CcSEcCtD
Letrozole—Palpitations—Docetaxel—lung cancer	7.76e-05	0.000393	CcSEcCtD
Letrozole—Feeling abnormal—Cisplatin—lung cancer	7.75e-05	0.000393	CcSEcCtD
Letrozole—Paraesthesia—Etoposide—lung cancer	7.74e-05	0.000392	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—RB1—lung cancer	7.74e-05	0.00127	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—lung cancer	7.71e-05	0.00126	CbGpPWpGaD
Letrozole—Musculoskeletal discomfort—Paclitaxel—lung cancer	7.7e-05	0.00039	CcSEcCtD
Letrozole—Dyspnoea—Etoposide—lung cancer	7.69e-05	0.000389	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—CYP1A1—lung cancer	7.67e-05	0.00126	CbGpPWpGaD
Letrozole—Somnolence—Etoposide—lung cancer	7.66e-05	0.000388	CcSEcCtD
Letrozole—Cough—Docetaxel—lung cancer	7.66e-05	0.000388	CcSEcCtD
Letrozole—Angina pectoris—Doxorubicin—lung cancer	7.66e-05	0.000388	CcSEcCtD
Letrozole—Hepatobiliary disease—Methotrexate—lung cancer	7.66e-05	0.000388	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	7.66e-05	0.00125	CbGpPWpGaD
Letrozole—Insomnia—Paclitaxel—lung cancer	7.64e-05	0.000387	CcSEcCtD
Letrozole—Paraesthesia—Paclitaxel—lung cancer	7.59e-05	0.000385	CcSEcCtD
Letrozole—Hypertension—Docetaxel—lung cancer	7.58e-05	0.000384	CcSEcCtD
Letrozole—Dyspnoea—Paclitaxel—lung cancer	7.54e-05	0.000382	CcSEcCtD
Letrozole—Somnolence—Paclitaxel—lung cancer	7.51e-05	0.000381	CcSEcCtD
Letrozole—Decreased appetite—Etoposide—lung cancer	7.49e-05	0.00038	CcSEcCtD
Letrozole—Chest pain—Docetaxel—lung cancer	7.47e-05	0.000379	CcSEcCtD
Letrozole—Arthralgia—Docetaxel—lung cancer	7.47e-05	0.000379	CcSEcCtD
Letrozole—Myalgia—Docetaxel—lung cancer	7.47e-05	0.000379	CcSEcCtD
Letrozole—Nausea—Vinorelbine—lung cancer	7.46e-05	0.000378	CcSEcCtD
Letrozole—Gastrointestinal disorder—Etoposide—lung cancer	7.44e-05	0.000377	CcSEcCtD
Letrozole—Dyspepsia—Paclitaxel—lung cancer	7.44e-05	0.000377	CcSEcCtD
Letrozole—Body temperature increased—Cisplatin—lung cancer	7.44e-05	0.000377	CcSEcCtD
Letrozole—Asthenia—Irinotecan—lung cancer	7.44e-05	0.000377	CcSEcCtD
Letrozole—Fatigue—Etoposide—lung cancer	7.43e-05	0.000377	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	7.42e-05	0.000376	CcSEcCtD
Letrozole—Pain—Etoposide—lung cancer	7.37e-05	0.000374	CcSEcCtD
Letrozole—Constipation—Etoposide—lung cancer	7.37e-05	0.000374	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	7.37e-05	0.00121	CbGpPWpGaD
Letrozole—Decreased appetite—Paclitaxel—lung cancer	7.35e-05	0.000372	CcSEcCtD
Letrozole—Dry mouth—Docetaxel—lung cancer	7.31e-05	0.00037	CcSEcCtD
Letrozole—Haemoglobin—Methotrexate—lung cancer	7.3e-05	0.00037	CcSEcCtD
Letrozole—Gastrointestinal disorder—Paclitaxel—lung cancer	7.3e-05	0.00037	CcSEcCtD
Letrozole—Fatigue—Paclitaxel—lung cancer	7.29e-05	0.000369	CcSEcCtD
Letrozole—Hepatitis—Methotrexate—lung cancer	7.27e-05	0.000368	CcSEcCtD
Letrozole—Haemorrhage—Methotrexate—lung cancer	7.27e-05	0.000368	CcSEcCtD
Letrozole—Pollakiuria—Doxorubicin—lung cancer	7.26e-05	0.000368	CcSEcCtD
Letrozole—Asthenia—Gemcitabine—lung cancer	7.24e-05	0.000367	CcSEcCtD
Letrozole—Constipation—Paclitaxel—lung cancer	7.23e-05	0.000366	CcSEcCtD
Letrozole—Pain—Paclitaxel—lung cancer	7.23e-05	0.000366	CcSEcCtD
Letrozole—CYP19A1—Metabolism—ATP5H—lung cancer	7.21e-05	0.00118	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—POMC—lung cancer	7.19e-05	0.00118	CbGpPWpGaD
Letrozole—Urinary tract disorder—Methotrexate—lung cancer	7.18e-05	0.000364	CcSEcCtD
Letrozole—Anaphylactic shock—Docetaxel—lung cancer	7.16e-05	0.000363	CcSEcCtD
Letrozole—Oedema—Docetaxel—lung cancer	7.16e-05	0.000363	CcSEcCtD
Letrozole—Weight increased—Doxorubicin—lung cancer	7.16e-05	0.000363	CcSEcCtD
Letrozole—Pruritus—Gemcitabine—lung cancer	7.14e-05	0.000362	CcSEcCtD
Letrozole—Urethral disorder—Methotrexate—lung cancer	7.12e-05	0.000361	CcSEcCtD
Letrozole—Infection—Docetaxel—lung cancer	7.12e-05	0.000361	CcSEcCtD
Letrozole—Weight decreased—Doxorubicin—lung cancer	7.11e-05	0.00036	CcSEcCtD
Letrozole—Feeling abnormal—Etoposide—lung cancer	7.1e-05	0.00036	CcSEcCtD
Letrozole—Diarrhoea—Irinotecan—lung cancer	7.09e-05	0.000359	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTA3—lung cancer	7.07e-05	0.00116	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Etoposide—lung cancer	7.05e-05	0.000357	CcSEcCtD
Letrozole—Nervous system disorder—Docetaxel—lung cancer	7.03e-05	0.000356	CcSEcCtD
Letrozole—Infestation NOS—Doxorubicin—lung cancer	7.01e-05	0.000355	CcSEcCtD
Letrozole—Infestation—Doxorubicin—lung cancer	7.01e-05	0.000355	CcSEcCtD
Letrozole—Tachycardia—Docetaxel—lung cancer	6.99e-05	0.000354	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	6.97e-05	0.00114	CbGpPWpGaD
Letrozole—Feeling abnormal—Paclitaxel—lung cancer	6.96e-05	0.000353	CcSEcCtD
Letrozole—Skin disorder—Docetaxel—lung cancer	6.96e-05	0.000353	CcSEcCtD
Letrozole—Gastrointestinal pain—Paclitaxel—lung cancer	6.91e-05	0.00035	CcSEcCtD
Letrozole—Diarrhoea—Gemcitabine—lung cancer	6.91e-05	0.00035	CcSEcCtD
Letrozole—Erythema multiforme—Methotrexate—lung cancer	6.87e-05	0.000348	CcSEcCtD
Letrozole—Dizziness—Irinotecan—lung cancer	6.85e-05	0.000347	CcSEcCtD
Letrozole—Urticaria—Etoposide—lung cancer	6.85e-05	0.000347	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—lung cancer	6.83e-05	0.000346	CcSEcCtD
Letrozole—Anorexia—Docetaxel—lung cancer	6.83e-05	0.000346	CcSEcCtD
Letrozole—Abdominal pain—Etoposide—lung cancer	6.81e-05	0.000345	CcSEcCtD
Letrozole—Body temperature increased—Etoposide—lung cancer	6.81e-05	0.000345	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—lung cancer	6.81e-05	0.000345	CcSEcCtD
Letrozole—Eye disorder—Methotrexate—lung cancer	6.79e-05	0.000344	CcSEcCtD
Letrozole—Asthenia—Cisplatin—lung cancer	6.75e-05	0.000342	CcSEcCtD
Letrozole—CYP2A6—Metabolism—COL4A3BP—lung cancer	6.75e-05	0.00111	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AZIN2—lung cancer	6.75e-05	0.00111	CbGpPWpGaD
Letrozole—Cardiac disorder—Methotrexate—lung cancer	6.74e-05	0.000342	CcSEcCtD
Letrozole—Sweating—Doxorubicin—lung cancer	6.72e-05	0.000341	CcSEcCtD
Letrozole—Urticaria—Paclitaxel—lung cancer	6.71e-05	0.00034	CcSEcCtD
Letrozole—Abdominal pain—Paclitaxel—lung cancer	6.68e-05	0.000339	CcSEcCtD
Letrozole—Body temperature increased—Paclitaxel—lung cancer	6.68e-05	0.000339	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—lung cancer	6.63e-05	0.000336	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	6.62e-05	0.00109	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—lung cancer	6.6e-05	0.00108	CbGpPWpGaD
Letrozole—Angiopathy—Methotrexate—lung cancer	6.59e-05	0.000334	CcSEcCtD
Letrozole—Vomiting—Irinotecan—lung cancer	6.59e-05	0.000334	CcSEcCtD
Letrozole—Mediastinal disorder—Methotrexate—lung cancer	6.55e-05	0.000332	CcSEcCtD
Letrozole—Rash—Irinotecan—lung cancer	6.53e-05	0.000331	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	6.53e-05	0.00107	CbGpPWpGaD
Letrozole—Dermatitis—Irinotecan—lung cancer	6.53e-05	0.000331	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Docetaxel—lung cancer	6.53e-05	0.000331	CcSEcCtD
Letrozole—Headache—Irinotecan—lung cancer	6.49e-05	0.000329	CcSEcCtD
Letrozole—Insomnia—Docetaxel—lung cancer	6.48e-05	0.000328	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTA4—lung cancer	6.46e-05	0.00106	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	6.45e-05	0.00106	CbGpPWpGaD
Letrozole—Diarrhoea—Cisplatin—lung cancer	6.44e-05	0.000326	CcSEcCtD
Letrozole—Paraesthesia—Docetaxel—lung cancer	6.43e-05	0.000326	CcSEcCtD
Letrozole—CYP19A1—Metabolism—PLBD1—lung cancer	6.43e-05	0.00105	CbGpPWpGaD
Letrozole—Alopecia—Methotrexate—lung cancer	6.42e-05	0.000325	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—lung cancer	6.42e-05	0.00105	CbGpPWpGaD
Letrozole—Vomiting—Gemcitabine—lung cancer	6.42e-05	0.000325	CcSEcCtD
Letrozole—Dyspnoea—Docetaxel—lung cancer	6.39e-05	0.000324	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	6.37e-05	0.00104	CbGpPWpGaD
Letrozole—Somnolence—Docetaxel—lung cancer	6.37e-05	0.000323	CcSEcCtD
Letrozole—Mental disorder—Methotrexate—lung cancer	6.37e-05	0.000323	CcSEcCtD
Letrozole—Rash—Gemcitabine—lung cancer	6.37e-05	0.000323	CcSEcCtD
Letrozole—Dermatitis—Gemcitabine—lung cancer	6.36e-05	0.000322	CcSEcCtD
Letrozole—Malnutrition—Methotrexate—lung cancer	6.33e-05	0.000321	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—lung cancer	6.33e-05	0.000321	CcSEcCtD
Letrozole—Headache—Gemcitabine—lung cancer	6.32e-05	0.00032	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	6.32e-05	0.00104	CbGpPWpGaD
Letrozole—Dyspepsia—Docetaxel—lung cancer	6.31e-05	0.00032	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTA2—lung cancer	6.3e-05	0.00103	CbGpPWpGaD
Letrozole—Hepatitis—Doxorubicin—lung cancer	6.29e-05	0.000319	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—lung cancer	6.29e-05	0.000319	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—lung cancer	6.26e-05	0.000317	CcSEcCtD
Letrozole—Decreased appetite—Docetaxel—lung cancer	6.23e-05	0.000316	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—lung cancer	6.21e-05	0.000315	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—lung cancer	6.2e-05	0.000314	CcSEcCtD
Letrozole—Dysgeusia—Methotrexate—lung cancer	6.2e-05	0.000314	CcSEcCtD
Letrozole—Gastrointestinal disorder—Docetaxel—lung cancer	6.18e-05	0.000313	CcSEcCtD
Letrozole—Asthenia—Etoposide—lung cancer	6.18e-05	0.000313	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—lung cancer	6.18e-05	0.000313	CcSEcCtD
Letrozole—Fatigue—Docetaxel—lung cancer	6.18e-05	0.000313	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—lung cancer	6.17e-05	0.000313	CcSEcCtD
Letrozole—Nausea—Irinotecan—lung cancer	6.16e-05	0.000312	CcSEcCtD
Letrozole—Constipation—Docetaxel—lung cancer	6.13e-05	0.00031	CcSEcCtD
Letrozole—Pain—Docetaxel—lung cancer	6.13e-05	0.00031	CcSEcCtD
Letrozole—Back pain—Methotrexate—lung cancer	6.12e-05	0.00031	CcSEcCtD
Letrozole—Pruritus—Etoposide—lung cancer	6.1e-05	0.000309	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTA1—lung cancer	6.08e-05	0.000996	CbGpPWpGaD
Letrozole—Asthenia—Paclitaxel—lung cancer	6.06e-05	0.000307	CcSEcCtD
Letrozole—Nausea—Gemcitabine—lung cancer	6e-05	0.000304	CcSEcCtD
Letrozole—Vomiting—Cisplatin—lung cancer	5.98e-05	0.000303	CcSEcCtD
Letrozole—Pruritus—Paclitaxel—lung cancer	5.98e-05	0.000303	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—lung cancer	5.96e-05	0.000302	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—lung cancer	5.95e-05	0.000302	CcSEcCtD
Letrozole—Rash—Cisplatin—lung cancer	5.93e-05	0.000301	CcSEcCtD
Letrozole—Dermatitis—Cisplatin—lung cancer	5.93e-05	0.0003	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—lung cancer	5.91e-05	0.000968	CbGpPWpGaD
Letrozole—Feeling abnormal—Docetaxel—lung cancer	5.9e-05	0.000299	CcSEcCtD
Letrozole—Diarrhoea—Etoposide—lung cancer	5.9e-05	0.000299	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—lung cancer	5.88e-05	0.000298	CcSEcCtD
Letrozole—CYP19A1—Metabolism—HSD17B10—lung cancer	5.88e-05	0.000963	CbGpPWpGaD
Letrozole—Ill-defined disorder—Methotrexate—lung cancer	5.87e-05	0.000297	CcSEcCtD
Letrozole—Gastrointestinal pain—Docetaxel—lung cancer	5.86e-05	0.000297	CcSEcCtD
Letrozole—Flushing—Doxorubicin—lung cancer	5.84e-05	0.000296	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—lung cancer	5.84e-05	0.000296	CcSEcCtD
Letrozole—Diarrhoea—Paclitaxel—lung cancer	5.78e-05	0.000293	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—lung cancer	5.75e-05	0.000942	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	5.74e-05	0.000941	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ATP5H—lung cancer	5.74e-05	0.000941	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—JUN—lung cancer	5.74e-05	0.00094	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—POMC—lung cancer	5.72e-05	0.000938	CbGpPWpGaD
Letrozole—Angiopathy—Doxorubicin—lung cancer	5.71e-05	0.000289	CcSEcCtD
Letrozole—Malaise—Methotrexate—lung cancer	5.71e-05	0.000289	CcSEcCtD
Letrozole—Dizziness—Etoposide—lung cancer	5.7e-05	0.000289	CcSEcCtD
Letrozole—Vertigo—Methotrexate—lung cancer	5.68e-05	0.000288	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—lung cancer	5.67e-05	0.000287	CcSEcCtD
Letrozole—Abdominal pain—Docetaxel—lung cancer	5.66e-05	0.000287	CcSEcCtD
Letrozole—Body temperature increased—Docetaxel—lung cancer	5.66e-05	0.000287	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—lung cancer	5.66e-05	0.000287	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—UGT1A1—lung cancer	5.65e-05	0.000926	CbGpPWpGaD
Letrozole—Dizziness—Paclitaxel—lung cancer	5.59e-05	0.000283	CcSEcCtD
Letrozole—Nausea—Cisplatin—lung cancer	5.59e-05	0.000283	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	5.57e-05	0.000913	CbGpPWpGaD
Letrozole—Alopecia—Doxorubicin—lung cancer	5.56e-05	0.000282	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—lung cancer	5.55e-05	0.000909	CbGpPWpGaD
Letrozole—Cough—Methotrexate—lung cancer	5.52e-05	0.00028	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—lung cancer	5.51e-05	0.000279	CcSEcCtD
Letrozole—Vomiting—Etoposide—lung cancer	5.48e-05	0.000278	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—lung cancer	5.48e-05	0.000278	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CKB—lung cancer	5.46e-05	0.000896	CbGpPWpGaD
Letrozole—Rash—Etoposide—lung cancer	5.44e-05	0.000275	CcSEcCtD
Letrozole—Dermatitis—Etoposide—lung cancer	5.43e-05	0.000275	CcSEcCtD
Letrozole—Headache—Etoposide—lung cancer	5.4e-05	0.000274	CcSEcCtD
Letrozole—Myalgia—Methotrexate—lung cancer	5.39e-05	0.000273	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—lung cancer	5.39e-05	0.000273	CcSEcCtD
Letrozole—Chest pain—Methotrexate—lung cancer	5.39e-05	0.000273	CcSEcCtD
Letrozole—Tension—Doxorubicin—lung cancer	5.38e-05	0.000272	CcSEcCtD
Letrozole—Vomiting—Paclitaxel—lung cancer	5.37e-05	0.000272	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—lung cancer	5.36e-05	0.000272	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.35e-05	0.000271	CcSEcCtD
Letrozole—Rash—Paclitaxel—lung cancer	5.33e-05	0.00027	CcSEcCtD
Letrozole—Dermatitis—Paclitaxel—lung cancer	5.32e-05	0.00027	CcSEcCtD
Letrozole—Discomfort—Methotrexate—lung cancer	5.32e-05	0.00027	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—lung cancer	5.32e-05	0.00027	CcSEcCtD
Letrozole—Back pain—Doxorubicin—lung cancer	5.3e-05	0.000269	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	5.3e-05	0.000868	CbGpPWpGaD
Letrozole—Headache—Paclitaxel—lung cancer	5.29e-05	0.000268	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—EP300—lung cancer	5.29e-05	0.000867	CbGpPWpGaD
Letrozole—Anaphylactic shock—Methotrexate—lung cancer	5.16e-05	0.000262	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—lung cancer	5.16e-05	0.000262	CcSEcCtD
Letrozole—Asthenia—Docetaxel—lung cancer	5.14e-05	0.00026	CcSEcCtD
Letrozole—CYP19A1—Metabolism—GSTM2—lung cancer	5.14e-05	0.000842	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CNDP2—lung cancer	5.14e-05	0.000842	CbGpPWpGaD
Letrozole—Infection—Methotrexate—lung cancer	5.13e-05	0.00026	CcSEcCtD
Letrozole—Nausea—Etoposide—lung cancer	5.12e-05	0.000259	CcSEcCtD
Letrozole—CYP2A6—Metabolism—PLBD1—lung cancer	5.11e-05	0.000838	CbGpPWpGaD
Letrozole—Ill-defined disorder—Doxorubicin—lung cancer	5.08e-05	0.000258	CcSEcCtD
Letrozole—Pruritus—Docetaxel—lung cancer	5.07e-05	0.000257	CcSEcCtD
Letrozole—Nervous system disorder—Methotrexate—lung cancer	5.06e-05	0.000257	CcSEcCtD
Letrozole—Nausea—Paclitaxel—lung cancer	5.02e-05	0.000254	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—lung cancer	5.02e-05	0.000254	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	5.01e-05	0.000821	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTMR3—lung cancer	5e-05	0.000819	CbGpPWpGaD
Letrozole—Hyperhidrosis—Methotrexate—lung cancer	4.99e-05	0.000253	CcSEcCtD
Letrozole—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	4.98e-05	0.000817	CbGpPWpGaD
Letrozole—Malaise—Doxorubicin—lung cancer	4.94e-05	0.00025	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—lung cancer	4.92e-05	0.000249	CcSEcCtD
Letrozole—Anorexia—Methotrexate—lung cancer	4.92e-05	0.000249	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—lung cancer	4.9e-05	0.000249	CcSEcCtD
Letrozole—Diarrhoea—Docetaxel—lung cancer	4.9e-05	0.000248	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	4.87e-05	0.000798	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PGAM1—lung cancer	4.87e-05	0.000798	CbGpPWpGaD
Letrozole—Palpitations—Doxorubicin—lung cancer	4.84e-05	0.000245	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—HPGDS—lung cancer	4.8e-05	0.000787	CbGpPWpGaD
Letrozole—Cough—Doxorubicin—lung cancer	4.78e-05	0.000242	CcSEcCtD
Letrozole—Dizziness—Docetaxel—lung cancer	4.74e-05	0.00024	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—lung cancer	4.73e-05	0.00024	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methotrexate—lung cancer	4.7e-05	0.000238	CcSEcCtD
Letrozole—CYP2A6—Metabolism—HSD17B10—lung cancer	4.68e-05	0.000767	CbGpPWpGaD
Letrozole—Insomnia—Methotrexate—lung cancer	4.67e-05	0.000237	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—lung cancer	4.66e-05	0.000236	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—lung cancer	4.66e-05	0.000236	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—lung cancer	4.66e-05	0.000236	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTT1—lung cancer	4.66e-05	0.000764	CbGpPWpGaD
Letrozole—Anxiety—Doxorubicin—lung cancer	4.65e-05	0.000236	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CYP2A7—lung cancer	4.65e-05	0.000761	CbGpPWpGaD
Letrozole—Paraesthesia—Methotrexate—lung cancer	4.64e-05	0.000235	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.63e-05	0.000235	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—lung cancer	4.61e-05	0.000756	CbGpPWpGaD
Letrozole—Discomfort—Doxorubicin—lung cancer	4.61e-05	0.000234	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—CYP2A6—lung cancer	4.6e-05	0.000755	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GCLC—lung cancer	4.6e-05	0.000755	CbGpPWpGaD
Letrozole—Dyspnoea—Methotrexate—lung cancer	4.6e-05	0.000233	CcSEcCtD
Letrozole—Somnolence—Methotrexate—lung cancer	4.59e-05	0.000233	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—lung cancer	4.56e-05	0.000231	CcSEcCtD
Letrozole—Vomiting—Docetaxel—lung cancer	4.55e-05	0.000231	CcSEcCtD
Letrozole—CYP19A1—Metabolism—SDC4—lung cancer	4.55e-05	0.000745	CbGpPWpGaD
Letrozole—Dyspepsia—Methotrexate—lung cancer	4.55e-05	0.00023	CcSEcCtD
Letrozole—Rash—Docetaxel—lung cancer	4.52e-05	0.000229	CcSEcCtD
Letrozole—Dermatitis—Docetaxel—lung cancer	4.51e-05	0.000229	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—lung cancer	4.51e-05	0.000739	CbGpPWpGaD
Letrozole—Decreased appetite—Methotrexate—lung cancer	4.49e-05	0.000227	CcSEcCtD
Letrozole—Headache—Docetaxel—lung cancer	4.49e-05	0.000227	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—lung cancer	4.47e-05	0.000227	CcSEcCtD
Letrozole—Oedema—Doxorubicin—lung cancer	4.47e-05	0.000227	CcSEcCtD
Letrozole—Gastrointestinal disorder—Methotrexate—lung cancer	4.46e-05	0.000226	CcSEcCtD
Letrozole—Fatigue—Methotrexate—lung cancer	4.45e-05	0.000226	CcSEcCtD
Letrozole—Infection—Doxorubicin—lung cancer	4.44e-05	0.000225	CcSEcCtD
Letrozole—Pain—Methotrexate—lung cancer	4.42e-05	0.000224	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—lung cancer	4.38e-05	0.000222	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—lung cancer	4.36e-05	0.000221	CcSEcCtD
Letrozole—CYP2A6—Metabolism—CKB—lung cancer	4.35e-05	0.000713	CbGpPWpGaD
Letrozole—Skin disorder—Doxorubicin—lung cancer	4.34e-05	0.00022	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—lung cancer	4.32e-05	0.000219	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—lung cancer	4.26e-05	0.000216	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—lung cancer	4.26e-05	0.000698	CbGpPWpGaD
Letrozole—Nausea—Docetaxel—lung cancer	4.26e-05	0.000216	CcSEcCtD
Letrozole—Feeling abnormal—Methotrexate—lung cancer	4.25e-05	0.000216	CcSEcCtD
Letrozole—Gastrointestinal pain—Methotrexate—lung cancer	4.22e-05	0.000214	CcSEcCtD
Letrozole—CYP19A1—Metabolism—RRM1—lung cancer	4.14e-05	0.000679	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTA3—lung cancer	4.14e-05	0.000679	CbGpPWpGaD
Letrozole—Urticaria—Methotrexate—lung cancer	4.1e-05	0.000208	CcSEcCtD
Letrozole—CYP2A6—Metabolism—CNDP2—lung cancer	4.09e-05	0.00067	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM2—lung cancer	4.09e-05	0.00067	CbGpPWpGaD
Letrozole—Abdominal pain—Methotrexate—lung cancer	4.08e-05	0.000207	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—lung cancer	4.08e-05	0.000207	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.07e-05	0.000206	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—lung cancer	4.04e-05	0.000205	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—lung cancer	4.01e-05	0.000203	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—lung cancer	3.99e-05	0.000202	CcSEcCtD
Letrozole—CYP2A6—Metabolism—MTMR3—lung cancer	3.98e-05	0.000652	CbGpPWpGaD
Letrozole—Somnolence—Doxorubicin—lung cancer	3.97e-05	0.000201	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	3.95e-05	0.000647	CbGpPWpGaD
Letrozole—Dyspepsia—Doxorubicin—lung cancer	3.94e-05	0.000199	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—CYP2E1—lung cancer	3.92e-05	0.000642	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—B4GALT5—lung cancer	3.89e-05	0.000638	CbGpPWpGaD
Letrozole—Decreased appetite—Doxorubicin—lung cancer	3.89e-05	0.000197	CcSEcCtD
Letrozole—CYP2A6—Metabolism—PGAM1—lung cancer	3.88e-05	0.000635	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	3.86e-05	0.000633	CbGpPWpGaD
Letrozole—Gastrointestinal disorder—Doxorubicin—lung cancer	3.86e-05	0.000196	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—lung cancer	3.85e-05	0.000195	CcSEcCtD
Letrozole—Constipation—Doxorubicin—lung cancer	3.82e-05	0.000194	CcSEcCtD
Letrozole—Pain—Doxorubicin—lung cancer	3.82e-05	0.000194	CcSEcCtD
Letrozole—CYP19A1—Metabolism—GSTA4—lung cancer	3.79e-05	0.000621	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—lung cancer	3.79e-05	0.000621	CbGpPWpGaD
Letrozole—Asthenia—Methotrexate—lung cancer	3.7e-05	0.000188	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.7e-05	0.000607	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2A7—lung cancer	3.7e-05	0.000606	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTA2—lung cancer	3.69e-05	0.000605	CbGpPWpGaD
Letrozole—Feeling abnormal—Doxorubicin—lung cancer	3.68e-05	0.000187	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—lung cancer	3.66e-05	0.000185	CcSEcCtD
Letrozole—Pruritus—Methotrexate—lung cancer	3.65e-05	0.000185	CcSEcCtD
Letrozole—CYP2A6—Metabolism—SDC4—lung cancer	3.62e-05	0.000593	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTA1—lung cancer	3.56e-05	0.000584	CbGpPWpGaD
Letrozole—Urticaria—Doxorubicin—lung cancer	3.55e-05	0.00018	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—lung cancer	3.53e-05	0.000179	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—lung cancer	3.53e-05	0.000179	CcSEcCtD
Letrozole—Diarrhoea—Methotrexate—lung cancer	3.53e-05	0.000179	CcSEcCtD
Letrozole—CYP19A1—Metabolism—ABCC3—lung cancer	3.52e-05	0.000577	CbGpPWpGaD
Letrozole—Dizziness—Methotrexate—lung cancer	3.41e-05	0.000173	CcSEcCtD
Letrozole—CYP19A1—Metabolism—AKR1C1—lung cancer	3.41e-05	0.000559	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—UGT1A1—lung cancer	3.31e-05	0.000543	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—RRM1—lung cancer	3.3e-05	0.00054	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA3—lung cancer	3.3e-05	0.00054	CbGpPWpGaD
Letrozole—Vomiting—Methotrexate—lung cancer	3.28e-05	0.000166	CcSEcCtD
Letrozole—Rash—Methotrexate—lung cancer	3.26e-05	0.000165	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—lung cancer	3.25e-05	0.000165	CcSEcCtD
Letrozole—Headache—Methotrexate—lung cancer	3.23e-05	0.000164	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTP1—lung cancer	3.23e-05	0.000529	CbGpPWpGaD
Letrozole—Asthenia—Doxorubicin—lung cancer	3.21e-05	0.000163	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—lung cancer	3.2e-05	0.000524	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GNG11—lung cancer	3.19e-05	0.000523	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	3.18e-05	0.000522	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.18e-05	0.000521	CbGpPWpGaD
Letrozole—Pruritus—Doxorubicin—lung cancer	3.16e-05	0.00016	CcSEcCtD
Letrozole—CYP2A6—Metabolism—B4GALT5—lung cancer	3.1e-05	0.000508	CbGpPWpGaD
Letrozole—Nausea—Methotrexate—lung cancer	3.07e-05	0.000155	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—lung cancer	3.06e-05	0.000155	CcSEcCtD
Letrozole—CYP19A1—Metabolism—ALDOA—lung cancer	3.04e-05	0.000498	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA4—lung cancer	3.01e-05	0.000494	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.97e-05	0.000486	CbGpPWpGaD
Letrozole—Dizziness—Doxorubicin—lung cancer	2.96e-05	0.00015	CcSEcCtD
Letrozole—CYP19A1—Metabolism—NCOA3—lung cancer	2.95e-05	0.000484	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA2—lung cancer	2.94e-05	0.000481	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.93e-05	0.00048	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.9e-05	0.000475	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ADCY1—lung cancer	2.87e-05	0.00047	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCG2—lung cancer	2.87e-05	0.00047	CbGpPWpGaD
Letrozole—Vomiting—Doxorubicin—lung cancer	2.84e-05	0.000144	CcSEcCtD
Letrozole—CYP2A6—Metabolism—GSTA1—lung cancer	2.83e-05	0.000465	CbGpPWpGaD
Letrozole—Rash—Doxorubicin—lung cancer	2.82e-05	0.000143	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—lung cancer	2.82e-05	0.000143	CcSEcCtD
Letrozole—CYP19A1—Metabolism—ENO2—lung cancer	2.81e-05	0.000461	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HPGDS—lung cancer	2.81e-05	0.000461	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.81e-05	0.000461	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCC3—lung cancer	2.8e-05	0.000459	CbGpPWpGaD
Letrozole—Headache—Doxorubicin—lung cancer	2.8e-05	0.000142	CcSEcCtD
Letrozole—CYP19A1—Metabolism—PPP2R1B—lung cancer	2.8e-05	0.000458	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.77e-05	0.000455	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.76e-05	0.000452	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTT1—lung cancer	2.73e-05	0.000447	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKR1C1—lung cancer	2.71e-05	0.000445	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2A6—lung cancer	2.7e-05	0.000442	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GCLC—lung cancer	2.7e-05	0.000442	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.69e-05	0.000441	CbGpPWpGaD
Letrozole—Nausea—Doxorubicin—lung cancer	2.66e-05	0.000135	CcSEcCtD
Letrozole—CYP2A6—Metabolism—UGT1A1—lung cancer	2.63e-05	0.000432	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ENO1—lung cancer	2.56e-05	0.000419	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.55e-05	0.000418	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GNG11—lung cancer	2.54e-05	0.000416	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.52e-05	0.000412	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.47e-05	0.000406	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AZIN2—lung cancer	2.47e-05	0.000406	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALDOA—lung cancer	2.42e-05	0.000396	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOA3—lung cancer	2.35e-05	0.000385	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2E1—lung cancer	2.29e-05	0.000376	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ADCY1—lung cancer	2.28e-05	0.000374	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCG2—lung cancer	2.28e-05	0.000374	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NQO1—lung cancer	2.27e-05	0.000372	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ENO2—lung cancer	2.24e-05	0.000367	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HPGDS—lung cancer	2.24e-05	0.000367	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPP2R1B—lung cancer	2.23e-05	0.000365	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.22e-05	0.000364	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.2e-05	0.000361	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTT1—lung cancer	2.17e-05	0.000356	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GCLC—lung cancer	2.15e-05	0.000352	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ATP5H—lung cancer	2.1e-05	0.000345	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—POMC—lung cancer	2.1e-05	0.000344	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—STK11—lung cancer	2.04e-05	0.000335	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ENO1—lung cancer	2.04e-05	0.000334	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.92e-05	0.000315	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTP1—lung cancer	1.89e-05	0.00031	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLBD1—lung cancer	1.88e-05	0.000307	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAT—lung cancer	1.84e-05	0.000302	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.83e-05	0.0003	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2E1—lung cancer	1.83e-05	0.000299	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NQO1—lung cancer	1.81e-05	0.000296	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCB1—lung cancer	1.79e-05	0.000294	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TYMS—lung cancer	1.76e-05	0.000288	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTM1—lung cancer	1.74e-05	0.000285	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD17B10—lung cancer	1.72e-05	0.000281	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1A1—lung cancer	1.65e-05	0.00027	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ERCC2—lung cancer	1.63e-05	0.000268	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—STK11—lung cancer	1.63e-05	0.000267	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CKB—lung cancer	1.59e-05	0.000261	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTP1—lung cancer	1.51e-05	0.000247	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM2—lung cancer	1.5e-05	0.000246	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CNDP2—lung cancer	1.5e-05	0.000246	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAT—lung cancer	1.47e-05	0.00024	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTMR3—lung cancer	1.46e-05	0.000239	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCB1—lung cancer	1.43e-05	0.000234	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PGAM1—lung cancer	1.42e-05	0.000233	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOA1—lung cancer	1.41e-05	0.000232	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TYMS—lung cancer	1.4e-05	0.000229	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM1—lung cancer	1.38e-05	0.000227	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2A7—lung cancer	1.36e-05	0.000222	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.35e-05	0.000222	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SDC4—lung cancer	1.33e-05	0.000217	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1A1—lung cancer	1.31e-05	0.000215	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ERCC2—lung cancer	1.3e-05	0.000213	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CG—lung cancer	1.29e-05	0.000212	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—POMC—lung cancer	1.23e-05	0.000201	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—RRM1—lung cancer	1.21e-05	0.000198	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA3—lung cancer	1.21e-05	0.000198	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CREBBP—lung cancer	1.2e-05	0.000196	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—B4GALT5—lung cancer	1.14e-05	0.000186	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CD—lung cancer	1.14e-05	0.000186	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOA1—lung cancer	1.13e-05	0.000185	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—lung cancer	1.12e-05	0.000184	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA4—lung cancer	1.11e-05	0.000181	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA2—lung cancer	1.08e-05	0.000177	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA1—lung cancer	1.04e-05	0.00017	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CG—lung cancer	1.03e-05	0.000168	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCC3—lung cancer	1.03e-05	0.000168	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKR1C1—lung cancer	9.95e-06	0.000163	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CB—lung cancer	9.89e-06	0.000162	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—lung cancer	9.8e-06	0.000161	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—POMC—lung cancer	9.78e-06	0.00016	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UGT1A1—lung cancer	9.66e-06	0.000158	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CREBBP—lung cancer	9.53e-06	0.000156	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GNG11—lung cancer	9.31e-06	0.000153	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CD—lung cancer	9.03e-06	0.000148	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—lung cancer	8.92e-06	0.000146	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALDOA—lung cancer	8.87e-06	0.000145	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOA3—lung cancer	8.61e-06	0.000141	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTEN—lung cancer	8.55e-06	0.00014	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ADCY1—lung cancer	8.38e-06	0.000137	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCG2—lung cancer	8.38e-06	0.000137	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ENO2—lung cancer	8.21e-06	0.000135	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HPGDS—lung cancer	8.21e-06	0.000135	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPP2R1B—lung cancer	8.16e-06	0.000134	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—EP300—lung cancer	8.15e-06	0.000134	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTT1—lung cancer	7.97e-06	0.000131	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2A6—lung cancer	7.87e-06	0.000129	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GCLC—lung cancer	7.87e-06	0.000129	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CB—lung cancer	7.87e-06	0.000129	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—lung cancer	7.8e-06	0.000128	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ENO1—lung cancer	7.46e-06	0.000122	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTEN—lung cancer	6.8e-06	0.000112	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2E1—lung cancer	6.7e-06	0.00011	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NQO1—lung cancer	6.62e-06	0.000109	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—EP300—lung cancer	6.49e-06	0.000106	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CA—lung cancer	6.03e-06	9.89e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—STK11—lung cancer	5.97e-06	9.78e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTP1—lung cancer	5.52e-06	9.05e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAT—lung cancer	5.37e-06	8.81e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCB1—lung cancer	5.23e-06	8.57e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TYMS—lung cancer	5.13e-06	8.41e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM1—lung cancer	5.07e-06	8.32e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—lung cancer	4.93e-06	8.08e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1A1—lung cancer	4.81e-06	7.88e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CA—lung cancer	4.8e-06	7.87e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ERCC2—lung cancer	4.77e-06	7.82e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOA1—lung cancer	4.13e-06	6.76e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—lung cancer	3.92e-06	6.43e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CG—lung cancer	3.77e-06	6.18e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—POMC—lung cancer	3.59e-06	5.88e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CREBBP—lung cancer	3.49e-06	5.73e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CD—lung cancer	3.31e-06	5.43e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—lung cancer	3.27e-06	5.36e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CB—lung cancer	2.89e-06	4.73e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—lung cancer	2.86e-06	4.69e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTEN—lung cancer	2.49e-06	4.09e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—EP300—lung cancer	2.38e-06	3.9e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CA—lung cancer	1.76e-06	2.88e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—lung cancer	1.44e-06	2.36e-05	CbGpPWpGaD
